Virtu Financial LLC Gossamer Bio, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$0.8 - $1.51 $14,771 - $27,880	-18,464 Reduced 56.13%	14,433 $17,000
Q4 2023 Feb 26, 2024	BUY	$0.48 - $1.08 $15,790 - $35,528	32,897 New	32,897 $30,000
Q3 2022 Nov 07, 2022	BUY	$7.21 - $14.88 $112,209 - $231,577	15,563 New	15,563 $186,000
Q1 2021 May 19, 2021	SELL	$8.63 - $10.94 $114,399 - $145,020	-13,256 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$8.3 - $13.59 $110,024 - $180,149	13,256 New	13,256 $128,000
Q3 2020 Dec 11, 2020	SELL	$11.3 - $14.75 $154,098 - $201,145	-13,637 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$9.52 - $15.98 $129,824 - $217,919	13,637 New	13,637 $177,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.